Lab
Florida Clinical Laboratory, INC
Florida Clinical Laboratory, INC was paid $549K by Medicaid between Jan 2018 and Sep 2024, across 128 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.
33Billing provider infoFLORIDA CLINICAL LABORATORY, INC
MELBOURNE, FL 32901
MELBOURNE, FL 32901
33aNPI1417062076assigned 08/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$549K
24GClaims421,302
24DCodes billed128
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#61 of 225
Median peer was paid$74K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 75,894 | $85K | |
| 2019 | 95,272 | $79K | |
| 2020 | 80,915 | $124K | |
| 2021 | 80,047 | $178K | |
| 2022 | 41,278 | $38K | |
| 2023 | 33,729 | $33K | |
| 2024incomplete | 14,167 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19% | 8,361 | 5,644 | $104K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.4% | 2,789 | 2,642 | $35K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 6.0% | 3,192 | 3,103 | $33K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5.8% | 5,689 | 5,282 | $32K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.3% | 2,796 | 2,646 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.0% | 41,305 | 32,043 | $27K |
| 80053 | Comprehensive metabolic panel | 4.9% | 46,801 | 34,225 | $27K |
| 84702 | 3.7% | 2,836 | 2,580 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.6% | 10,622 | 8,311 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.5% | 24,102 | 18,604 | $19K |
| 86762 | 3.3% | 2,759 | 2,710 | $18K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.3% | 2,026 | 1,845 | $18K |
116 more codes
| 87340 | 3.2% | 4,455 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.2% | 19,751 | $12K |
| 86787 | 2.1% | 1,540 | $11K | |
| 80061 | Lipid panel | 2.0% | 27,799 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 7,644 | $9K |
| 86592 | 1.6% | 5,668 | $9K | |
| 86850 | 1.5% | 2,518 | $8K | |
| 82607 | <1% | 10,049 | $5K | |
| 86803 | <1% | 1,931 | $5K | |
| 82728 | <1% | 6,702 | $4K | |
| 82947 | <1% | 2,217 | $4K | |
| 82746 | <1% | 7,664 | $3K | |
| 81001 | <1% | 22,116 | $3K | |
| 86900 | <1% | 2,422 | $3K | |
| 86901 | <1% | 2,415 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,515 | $3K |
| 82950 | <1% | 1,514 | $3K | |
| 84439 | <1% | 7,977 | $3K | |
| 84403 | <1% | 1,787 | $2K | |
| 87077 | <1% | 3,483 | $2K | |
| 83550 | <1% | 7,004 | $2K | |
| 82378 | <1% | 1,889 | $2K | |
| 84153 | <1% | 3,543 | $2K | |
| 84481 | <1% | 1,615 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,739 | $2K |
| 87186 | <1% | 2,042 | $2K | |
| 87070 | <1% | 772 | $2K | |
| 87088 | <1% | 2,936 | $2K | |
| 83540 | <1% | 7,965 | $2K | |
| 83970 | <1% | 1,548 | $2K | |
| 80074 | <1% | 340 | $1K | |
| 99199 | Unlisted special service, procedure or report | <1% | 661 | $1K |
| 82951 | <1% | 185 | $1K | |
| 82570 | <1% | 9,598 | $1K | |
| 83735 | <1% | 3,082 | $926.35 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,627 | $919.24 |
| 82670 | <1% | 382 | $893.90 | |
| 86480 | <1% | 37 | $856.10 | |
| 84550 | <1% | 5,571 | $824.87 | |
| 84436 | <1% | 2,980 | $786.46 | |
| 86300 | <1% | 694 | $748.13 | |
| 86696 | <1% | 175 | $748.11 | |
| 83001 | <1% | 467 | $735.95 | |
| 84144 | <1% | 286 | $726.66 | |
| 83615 | <1% | 2,654 | $687.41 | |
| 84480 | <1% | 1,558 | $620.51 | |
| 82248 | <1% | 2,365 | $606.47 | |
| 87480 | <1% | 86 | $577.44 | |
| 82043 | <1% | 8,701 | $567.19 | |
| 82784 | <1% | 308 | $564.01 | |
| 86769 | <1% | 802 | $517.47 | |
| 85660 | <1% | 342 | $516.31 | |
| 86706 | <1% | 152 | $477.50 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $476.74 |
| 85610 | <1% | 3,225 | $474.76 | |
| 85730 | <1% | 1,504 | $461.73 | |
| 82977 | <1% | 1,110 | $406.22 | |
| 83002 | <1% | 344 | $401.32 | |
| 85651 | <1% | 2,148 | $393.14 | |
| 86704 | <1% | 254 | $358.16 | |
| 84100 | <1% | 1,809 | $355.82 | |
| 84156 | <1% | 1,644 | $347.33 | |
| 86695 | <1% | 135 | $333.60 | |
| 86140 | <1% | 2,341 | $332.98 | |
| 87660 | <1% | 87 | $288.72 | |
| 87510 | <1% | 87 | $288.72 | |
| 80164 | <1% | 307 | $288.61 | |
| 84146 | <1% | 198 | $257.12 | |
| 82952 | <1% | 169 | $237.80 | |
| 82652 | <1% | 985 | $226.36 | |
| 85027 | <1% | 478 | $189.63 | |
| 88141 | <1% | 24 | $175.40 | |
| 84154 | <1% | 739 | $173.39 | |
| 86708 | <1% | 136 | $173.24 | |
| 84479 | <1% | 619 | $158.36 | |
| 85045 | <1% | 1,261 | $154.72 | |
| 86431 | <1% | 552 | $146.26 | |
| 82040 | <1% | 445 | $112.96 | |
| 82575 | <1% | 317 | $111.36 | |
| 82140 | <1% | 63 | $101.30 | |
| 86780 | <1% | 12 | $93.15 | |
| 80051 | <1% | 314 | $76.00 | |
| 84075 | <1% | 371 | $66.74 | |
| 84450 | <1% | 382 | $66.25 | |
| 84460 | <1% | 377 | $63.80 | |
| 84155 | <1% | 440 | $62.45 | |
| 82247 | <1% | 342 | $60.29 | |
| 86141 | <1% | 229 | $50.56 | |
| 88142 | <1% | 13 | $49.56 | |
| 82310 | <1% | 360 | $46.10 | |
| 83880 | <1% | 73 | $39.26 | |
| 84520 | <1% | 370 | $37.56 | |
| 84478 | <1% | 72 | $26.16 | |
| 83690 | <1% | 63 | $25.50 | |
| 82465 | <1% | 86 | $22.24 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 983 | $21.68 |
| 83090 | <1% | 260 | $20.36 | |
| 82565 | <1% | 84 | $20.04 | |
| 82550 | <1% | 303 | $19.46 | |
| 82150 | <1% | 29 | $14.09 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 276 | $12.42 |
| 82274 | <1% | 179 | $12.20 | |
| 84300 | <1% | 28 | $11.08 | |
| 84133 | <1% | 28 | $10.81 | |
| 82436 | <1% | 24 | $8.94 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 848 | $8.28 |
| 86709 | <1% | 20 | $7.65 | |
| 84295 | <1% | 22 | $2.35 | |
| 84132 | <1% | 23 | $2.32 | |
| 82435 | <1% | 23 | $2.24 | |
| 87634 | 0% | 19 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 19 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 19 | $0.00 |
| 80050 | General health panel | 0% | 33 | $0.00 |
| 82139 | 0% | 19 | $0.00 | |
| 84134 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHMID, MICHAEL (SVP, CHIEF FINANCIAL OFFICER)
Parent organizationBIOREFERENCE HEALTH, LLC
| Provider | Location | Paid |
|---|---|---|
| Bioreference Health, LLC | Elmwood Park, NJ | $620.07M |
| Bioreference Health, LLC | Houston, TX | $8.87M |
| Bioreference Health, LLC | Mineola, NY | $175K |
| Bioreference Health, LLC | Houston, TX | $117K |
| Bioreference Health, LLC | Burbank, CA | $25K |
| Bioreference Health, LLC | Gaithersburg, MD | $8K |
| Bioreference Health, LLC | Hackensack, NJ | $22.86 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.